# A Study to Investigate the Safety and Effectiveness of SAR448851 in Participants With Early Alzheimer's Disease

> **NCT07688213** · PHASE2 · RECRUITING · sponsor: **Sanofi** · enrollment: 160 (estimated)

## Conditions studied

- Dementia, Alzheimer's Type
- Alzheimer's Disease

## Interventions

- **DRUG:** SAR448851
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07688213
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-07-28
- **Primary completion:** 2029-07-31
- **Final completion:** 2029-07-31
- **Target enrollment:** 160 (ESTIMATED)
- **Last updated:** 2026-09-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07688213

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07688213, "A Study to Investigate the Safety and Effectiveness of SAR448851 in Participants With Early Alzheimer's Disease". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07688213. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*